Edition:
United States

Sinovac Biotech Ltd (SVA.OQ)

SVA.OQ on NASDAQ Stock Exchange Global Select Market

7.88USD
19 Apr 2018
Change (% chg)

$0.50 (+6.78%)
Prev Close
$7.38
Open
$7.16
Day's High
$7.88
Day's Low
$7.16
Volume
25,085
Avg. Vol
26,421
52-wk High
$8.75
52-wk Low
$4.60

Select another date:

Tue, Mar 6 2018

BRIEF-Sinovac Amends Shareholder Rights Plan

* SINOVAC BIOTECH LTD - ‍AMENDMENT EXTENDS EXPIRATION OF SHAREHOLDER RIGHTS PLAN FROM MARCH 27 TO MARCH 27, 2019​ Source text for Eikon: Further company coverage:

BRIEF-Sinovac Provides Update On Going Private Transaction

* SINOVAC BIOTECH - EXPECTS TO FILE AMENDED GOING-PRIVATE STATEMENT, INCLUDING A DEFINITIVE PROXY STATEMENT AS AN EXHIBIT, WITH U.S. SEC IN DUE COURSE Source text for Eikon: Further company coverage:

BRIEF-Sinovac Biotech Receives Positive Decision On Hepatitis A Vaccine From WHO

* SINOVAC BIOTECH RECEIVES POSITIVE DECISION ON ITS HEPATITIS A VACCINE FROM WORLD HEALTH ORGANIZATION

BRIEF-Sinovac Biotech Announces Update On Nasdaq Matters

* SINOVAC BIOTECH- ‍NASDAQ HEARINGS PANEL GRANTED REQUEST TO EXTEND STAY OF SUSPENSION IN TRADING OF CO'S COMMON SHARES PENDING HEARING ON JAN 11, 2018​ Source text for Eikon: Further company coverage:

BRIEF-Sinovac reports Q4 earnings per share $0.08

* Sinovac files 2016 annual report on form 20-F and reports unaudited fourth quarter 2016 financial results

BRIEF-Sinovac Biotech receives delisting determination letter from Nasdaq

* Sinovac Biotech announces receipt of delisting determination letter from Nasdaq Source text for Eikon: Further company coverage:

Select another date: